verified
SJR 0,45 · Q3
•
database
Scopus / SJR & Web of Science indexed
France · Elsevier Masson s.r.l.
workspace_premium
Q3 — Oncology
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique is a journal indexed in SJR in Oncology and Radiology, Nuclear Medicine and Imaging with an H index of 39. It has an SJR impact factor of 0,45 and it has a best quartile of Q3. It has an SJR impact factor of 0,45.
ISSN: 1278-3218
Publisher: Elsevier Masson s.r.l.
Category: Oncology
Indexation:
verifiedScopus / SJR
verifiedWeb of Science
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,45
Q3
H-index
39
Acceptance rate
pie_chart
35%
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
Web of Science
SJR Impact
0,45
H-index
39
Docs (year)
99
Docs 3y
386
Total refs
4526
Cites 3y
565
Citable 3y
374
Cites/Doc 2y
1.5
Ref/Doc
45.72
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.